Evidence map›Paper›PMID 38818506›Full record

ArticleFrontiers in endocrinology2024

Diagnostic value of FNAC combined with BRAF

Jingyao Fu, Xiangdang Yin, Xiaochun Wang, Siqi Xiao, Xianji Wu, Chengcheng Duan, Wenxi Yu, Guang Zhang

Registry-linked trialAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in endocrinology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06901908 (Role of Cytomorphometry and BRAFV600E Immunocytochemistry With a Cytologic Diagnosis "Suspicious for Papillary Thyroid Carcinoma"), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06901908 not yet recruitingnot on this mapstarted 2025, after this paper: background citation

Role of Cytomorphometry and BRAFV600E Immunocytochemistry With a Cytologic Diagnosis "Suspicious for Papillary Thyroid Carcinoma"

TypeobservationalSponsorAssiut UniversityRan2025 to 2027Enrolled45ConditionsSuspicious for Papillary Thyroid Carcinoma
3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jingyao FuDepartment of Thyroid Surgery, China-Japan Union Hospital of Jilin University, Changchun, Jilin, China.
Xiangdang YinDepartment of Oral-Maxillofacial-Thyroid Oncosurgery, Jilin Cancer Hospital, Changchun, Jilin, China.
Xiaochun WangDepartment of Oral-Maxillofacial-Thyroid Oncosurgery, Jilin Cancer Hospital, Changchun, Jilin, China.
Siqi XiaoDepartment of Thyroid Surgery, China-Japan Union Hospital of Jilin University, Changchun, Jilin, China.
Xianji WuDepartment of Thyroid Surgery, China-Japan Union Hospital of Jilin University, Changchun, Jilin, China.
Chengcheng DuanDepartment of Thyroid Surgery, China-Japan Union Hospital of Jilin University, Changchun, Jilin, China.
Wenxi YuDepartment of Thyroid Surgery, China-Japan Union Hospital of Jilin University, Changchun, Jilin, China.
Guang ZhangDepartment of Thyroid Surgery, China-Japan Union Hospital of Jilin University, Changchun, Jilin, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: This study aimed to analyze the effect of preoperative fine needle aspiration cytology (FNAC) combined with BRAF Method: Patients with thyroid nodules in Hashimoto's thyroiditis, who underwent fine-needle aspiration cytology examination and BRAF Results: For PTC patients with HT, the sensitivity of FNAC diagnosis was 93.69%, the specificity was 90.90% and the accuracy was 93.44%. However, the sensitivity, specificity and accuracy of FNAC combined with BRAF Conclusion: FNAC combined with eluent BRAF

Indexed as

Hashimoto DiseaseMutationProto-Oncogene Proteins B-rafThyroid Cancer, PapillaryThyroid NeoplasmsAdultAgedBiopsy, Fine-NeedleDNA Mutational AnalysisFemaleHumansMaleMiddle AgedSensitivity and SpecificityBRAF protein, humanProto-Oncogene Proteins B-rafBRAFV600E mutationdiagnosisfine needle aspiration cytologyHashimoto’s thyroiditispapillary thyroid carcinoma

Identifiers

PMID38818506
PMCPMC11137241

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.